Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors of this article are employees of McKinsey & Company, a management consultancy that works with the world's leading biopharmaceutical companies on R&D productivity issues. The analysis in this study was funded by McKinsey's Pharmaceuticals and Medical Products practice and undertaken independently of any other organizations.
Supplementary information
Supplementary information S1 (box)
Data and analysis (PDF 208 kb)
PowerPoint slides
Rights and permissions
About this article
Cite this article
Smietana, K., Ekstrom, L., Jeffery, B. et al. Improving R&D productivity. Nat Rev Drug Discov 14, 455–456 (2015). https://doi.org/10.1038/nrd4650
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4650
- Springer Nature Limited
This article is cited by
-
How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment
PharmacoEconomics (2021)
-
Prioritizing multiple therapeutic targets in parallel using automated DNA-encoded library screening
Nature Communications (2017)
-
This time may be different
Nature Biotechnology (2016)